GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lonza Group Ltd (MEX:LONN) » Definitions » Other Operating Expense

Lonza Group (MEX:LONN) Other Operating Expense : MXN4,929 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Lonza Group Other Operating Expense?

Lonza Group's Other Operating Expense for the six months ended in Jun. 2024 was MXN512 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 was MXN4,929 Mil.

Lonza Group's quarterly Other Operating Expense increased from Jun. 2023 (MXN248 Mil) to Dec. 2023 (MXN4,416 Mil) but then declined from Dec. 2023 (MXN4,416 Mil) to Jun. 2024 (MXN512 Mil).

Lonza Group's annual Other Operating Expense declined from Dec. 2021 (MXN9,778 Mil) to Dec. 2022 (MXN3,327 Mil) and declined from Dec. 2022 (MXN3,327 Mil) to Dec. 2023 (MXN2,611 Mil).


Lonza Group Other Operating Expense Historical Data

The historical data trend for Lonza Group's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lonza Group Other Operating Expense Chart

Lonza Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,456.83 2,888.42 9,778.12 3,327.46 2,610.52

Lonza Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 829.44 4,478.47 247.52 4,416.29 512.42

Lonza Group Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was MXN4,929 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lonza Group Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Lonza Group's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Lonza Group Business Description

Address
Muenchensteinerstrasse 38, Basel, CHE, CH-4002
Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

Lonza Group Headlines

No Headlines